The independent source for health policy research, polling, and news.
1-20 of 477 results
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue, records show.
ýҕl Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
The agreements, covering issues like drug pricing, reducing the use of synthetic food dyes, and cutting back on insurance prior authorization rules, were announced with fanfare and touted as victories. But it’s not clear whether they’ll result in lasting change.
Patients and researchers point to evidence that many cancer drug dosages are excessive, and that reducing the amount and frequency could save billions of dollars and prevent some of the worst side effects.
The way people undergo abortions has changed. This video details five things to know.
ýҕl Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
The recent outbreak of a foodborne parasite sickened thousands and hospitalized hundreds across the U.S. before federal investigators identified the suspected source. Food safety experts say cuts to the public health system hobbled the response — and that the next outbreak could be much worse.
California’s laws still leave extradition decisions related to reproductive rights and gender-affirming care to its governor. But as states with abortion bans target California physicians who prescribe abortion pills across state lines, Democrats want to lock in protections for doctors, no matter who the next governor is.
When makers of infant formula hear that babies got sick or died while using their products, what happens next is left largely to the manufacturers. They decide whether to inform the FDA about possible harm, which could trigger steps to protect the public.
ýҕl Health News journalists made the rounds on national media last week to discuss topical stories. Here’s a collection of their appearances.
As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
Four years after the Volunteer State enacted the nation’s first law allowing drugstores to sell ivermectin without patient-specific prescriptions, dozens of pharmacies dispense the drug in highly concentrated pills — many with the help of one anti-vaccine physician.
The Trump administration has pursued an extensive pro-tobacco agenda as the president and his political movement have been buoyed by a flood of tobacco industry money, federal records show.
The FDA has approved the sunscreen chemical bemotrizinol, a UV light filter that has been available in Europe, Asia, and Australia for more than 20 years. Health advocates and skin care industry groups alike are hopeful it can restore faith in sunscreen.
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile, researchers and doctors are concerned that some of these online companies aren't properly screening or monitoring patients. “It gives a black eye to telemedicine,” one researcher said.
Infectious disease specialists say the viruses are unlikely to become pandemics, but some are still raising concerns about the federal health response and what it portends should a pandemic similar to or worse than covid occur.
Podcast host Julie Rovner chats with Sen. Tammy Baldwin, a top Democrat on health issues, about President Donald Trump’s stewardship of federal spending and the effectiveness of the 988 Suicide & Crisis Lifeline.
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
For all of President Donald Trump’s showmanship, the share of Americans his policies will likely help remains slim, even if some patients do come out ahead.
ýҕl Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
© 2026 KFF